-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Morgan Stanley Adjusts Price Target on Axonics to $76 From $92, Maintains Overweight Rating

Morgan Stanley Adjusts Price Target on Axonics to $76 From $92, Maintains Overweight Rating

MT Newswires · 01/06/2023 05:44